About FDA

CDRH Transparency: Compliance & Enforcement

The FDA conducts inspections of medical device manufacturers to check that they are complying with medical device regulatory requirements. When a medical device manufacturer fails to comply with these requirements, the FDA responds with tools that include warning letters and recalls. In most cases, a company (manufacturer, distributor, or other responsible party) will take voluntary action to correct the violations identified by the FDA.

The CDRH Inspections Database provides information about FDA medical device inspections from 2008 to the present. The database contains information about the firms, types of devices and inspections, and links to warning letters (when available).

Each year, the FDA conducts inspections of medical device manufacturers to assess compliance with regulatory requirements, including the Quality System regulation. These inspections can result in the issuance of document known as a “Form 483,” named for the form on which the investigator records any observations.

After an inspection, FDA staff reviews the Form 483 and decides whether agency action is needed to assure correction of the cited violations.

In the interest of supporting better quality medical devices and communication with  industry, the FDA is providing data related to 2010 through 2015 quality system observations. Please follow the links below for information on warning letter citations and inspection observations for these years.

Page Last Updated: 09/19/2016
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English